Rxo (RXO) Enterprise Value (2021 - 2025)
Historic Enterprise Value for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to -$17.0 million.
- Rxo's Enterprise Value rose 5142.86% to -$17.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$17.0 million, marking a year-over-year increase of 5142.86%. This contributed to the annual value of -$17.0 million for FY2025, which is 5142.86% up from last year.
- Per Rxo's latest filing, its Enterprise Value stood at -$17.0 million for Q4 2025, which was up 5142.86% from -$25.0 million recorded in Q3 2025.
- Rxo's Enterprise Value's 5-year high stood at -$5.0 million during Q4 2023, with a 5-year trough of -$187.0 million in Q3 2022.
- Over the past 5 years, Rxo's median Enterprise Value value was -$29.0 million (recorded in 2021), while the average stood at -$56.5 million.
- Its Enterprise Value has fluctuated over the past 5 years, first soared by 9489.8% in 2023, then tumbled by 60000.0% in 2024.
- Quarter analysis of 5 years shows Rxo's Enterprise Value stood at -$29.0 million in 2021, then crashed by 237.93% to -$98.0 million in 2022, then surged by 94.9% to -$5.0 million in 2023, then plummeted by 600.0% to -$35.0 million in 2024, then skyrocketed by 51.43% to -$17.0 million in 2025.
- Its Enterprise Value was -$17.0 million in Q4 2025, compared to -$25.0 million in Q3 2025 and -$18.0 million in Q2 2025.